BIOASIS TECHNOLOGIES INCBIOASIS TECHNOLOGIES INCBIOASIS TECHNOLOGIES INC

BIOASIS TECHNOLOGIES INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪270.54 K‬EUR
‪78.07 M‬
Beta (1Y)
21.56

About Bioasis Technologies Inc.


CEO
Deborah A. Rathjen
Website
Headquarters
New Haven
Founded
2006
FIGI
BBG00J3708M7
biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 107 is 0.00 EUR — it hasn't changed in the past 24 hours. Watch BIOASIS TECHNOLOGIES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange BIOASIS TECHNOLOGIES INC stocks are traded under the ticker 107.
107 reached its all-time high on Apr 10, 2014 with the price of 33.85 EUR, and its all-time low was 0.0005 EUR and was reached on Jun 5, 2023. View more price dynamics on 107 chart.
See other stocks reaching their highest and lowest prices.
107 stock is 0.00% volatile and has beta coefficient of 21.56. Track BIOASIS TECHNOLOGIES INC stock price on the chart and check out the list of the most volatile stocks — is BIOASIS TECHNOLOGIES INC there?
Today BIOASIS TECHNOLOGIES INC has the market capitalization of ‪269.37 K‬, it has decreased by −37.54% over the last week.
Yes, you can track BIOASIS TECHNOLOGIES INC financials in yearly and quarterly reports right on TradingView.
BIOASIS TECHNOLOGIES INC is going to release the next earnings report on Jan 17, 2025. Keep track of upcoming events with our Earnings Calendar.
No, 107 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 107 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOASIS TECHNOLOGIES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOASIS TECHNOLOGIES INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOASIS TECHNOLOGIES INC stock shows the sell signal. See more of BIOASIS TECHNOLOGIES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.